Has Erik Pioro received payments from drug or device companies?

Yes. Drug and device makers reported $45,059 in general payments to Erik Pioro across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erik Pioro did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erik Pioro come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erik Pioro

Neuromuscular Medicine · Chicago, ILNPI 1154357499

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,160 of the $45,059 with a category attached, or 78.0%. Tanabe Pharma America, Inc. accounts for 64.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $13,923 and has fallen 67.1% since, to $4,577 in 2025.

$45,059in general payments, 2019–2025

Across 54 payments — averaging $834.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tanabe Pharma America, Inc.$29K
Avanir Pharmaceuticals, Inc.$6K
Amylyx Pharmaceuticals, Inc.$4K
Biogen$3K
Mitsubishi Tanabe Pharma Development America, Inc.$1K
Vertex$600
plus $119 from 1 others

$470,761in research payments, 2019–2025

Across 15 payments — averaging $31,384 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biogen$438K
Mitsubishi Tanabe Pharma Development America, Inc.$18K
AstraZeneca$15K

What the payments were for

Consulting fees$35,16078%
Speaking & faculty fees$3,6788%
Travel & lodging$4,1439%
Food & beverage$2,0775%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tanabe Pharma America, Inc.	29	$29,179
Avanir Pharmaceuticals, Inc.	1	$6,270
Amylyx Pharmaceuticals, Inc.	6	$4,379
Biogen	1	$3,131
Mitsubishi Tanabe Pharma Development America, Inc.	14	$1,382
Vertex	2	$600
AstraZeneca	1	$119

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Radicava$24,089
Radicava ORS$14,334
NUEDEXTA$6,270
RELYVRIO$4,346
EXSERVAN$1,100
ULTOMIRIS$119

How this compares

$45,059 in reported general payments places this provider in the 85th percentile of 21 neuromuscular medicine providers in Illinois.

See all neuromuscular medicine providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Radicava OrsEdaravone	42	$584,393
Riluzole	15	$2,682

Paid to pharmacies, not to this prescriber.

Other neuromuscular medicine in Chicago

Abigail SchwaedeChicago$73K
Arjun SethChicago$72K
Senda Ajroud DrissChicago$23K
Robert KalbChicago$22K
Daniela MenichellaChicago$11K
Robert SufitChicago$4K
Richard HarveyChicago$3K
Kyle MardenChicago$1K
Gyeongmo SohnChicago$1K
Adenike AdewuyiChicago$495

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →